Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 15 Sept 2026 for Ultragenyx Pharmaceutical Inc., €15k. Read the official filing
Filing timeline
BuySaleTheodore Alan Huizenga
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Theodore Alan Huizenga: trading record in brief
Theodore Alan Huizenga (senior executive) discloses dealings in Ultragenyx Pharmaceutical Inc. to SEC (Form 4). Between 14 January 2016 and 15 September 2026, the trades on record add up to 27 filings.
On the market, this insider has only sold: 12 sales, €242k in total. The rest of the record consists of 10 share grants and 3 option exercises. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 15 September 2026, reports an open-market sale of €15k in Ultragenyx Pharmaceutical Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Theodore Alan Huizenga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
1,283 shares@ US$13.57Common StockSEC:0001193125-26-392233:0
161 shares@ US$13.990.0001% mcap0.6% of flowCommon StockSEC:0001193125-26-384878:0
20,241 shares0Common StockSEC:0001193125-26-177470:0
148 shares@ US$23.390.9% of flowCommon StockSEC:0001193125-26-089109:0
85 shares@ US$34.380.8% of flowCommon StockSEC:0001193125-25-336619:0
64 shares@ US$29.170.5% of flowCommon StockSEC:0001193125-25-209387:0
84 shares@ US$31.390.7% of flowCommon StockSEC:0000950170-25-113446:0
9,392 shares0Common StockSEC:0000950170-25-032764:0
648 shares0Common StockSEC:0000950170-24-135525:0
700 shares0Common StockSEC:0000950170-24-107677:0
91 shares@ US$56.191.4% of flowCommon StockSEC:0000950170-24-103807:0
14 shares@ US$42.310.2% of flowCommon StockSEC:0000950170-24-045670:0
13,950 shares0Common StockSEC:0000950170-24-026641:0
1,000 shares0Common StockSEC:0001209191-24-000070:0
2,000 shares@ US$21.0011.9% of flowCommon StockSEC:0001209191-23-048905:0
883 shares@ US$37.049.1% of flowCommon StockSEC:0001209191-23-048489:0
3,000 shares@ US$21.0017.4% of flowCommon StockSEC:0001209191-23-028585:0
14 shares@ US$38.200.1% of flowCommon StockSEC:0001209191-23-024685:0
7,590 shares0Common StockSEC:0001209191-23-016045:0
639 shares@ US$43.407.9% of flowCommon StockSEC:0001209191-23-014502:0
2,031 shares@ US$43.9625.5% of flowCommon StockSEC:0001209191-22-062400:0
1,000 shares0Common StockSEC:0001209191-22-049222:0
132 shares@ US$84.553.2% of flowCommon StockSEC:0001209191-22-024699:0
843 shares@ US$66.6215.4% of flowCommon StockSEC:0001209191-22-015819:0
819 shares0Common StockSEC:0001209191-21-060756:0
25 of 27 declarations
